ERS | monograph Guest Editors Marcus A. Mall Marcus A. Mall is Professor of Paediatrics and director of the Dept of Translational Pulmonology at the Heidelberg University Medical School, and head of the Division of Paediatric Pulmonology and Allergy and the Cystic Fibrosis Center at the Dept of Paediatrics, University Hospital Heidelberg, Heidelberg, Germany. In 2011, he was appointed director of the Translational Lung Research Center Heidelberg (TLRC) and member of the board of directors of the German Center for Lung Research (DZL). He is an active member of several professional societies, including the European Cystic Fibrosis Society (ECFS), the European Respiratory Society (ERS) and the American Thoracic Society (ATS). He serves on journal editorial boards and on the scientific committee of the ECFS. Marcus Mall qualified in medicine at the University of Freiburg, Freiburg, Germany, and received his clinical training at the Univer- sities of Freiburg and Heidelberg, and his postdoctoral training at the University of North Carolina at Chapel Hill, NC, USA, where he was appointed Assistant Professor of Medicine. In 2005, he received a grant from the European Commission to establish a Marie Curie Excellence Team at the University of Heidelberg, and in 2009 he was awarded the prestigious Heisenberg Professorship by the German Research Foundation. He is board certified in paediatrics, paediatric pulmonology and infectious diseases. Marcus Mall’s research is focused on the cellular and molecular pathogenesis of CF and other airway diseases, and the develop- ment of novel diagnostic approaches and therapeutic strategies. His research programme has been funded by the German Research Foundation (DFG), the German Ministry for Education and Research (BMBF), the European Commission, and others, and he has received several research awards. He developed a mouse that overexpresses the epithelial sodium channel (bENaC), the first animal model with CF-like lung disease. He coordinates interdisciplinary translational research projects, integrating basic research with cohort studies and early phase clinical trials, to improve our understanding of CF lung disease and the translation of research results into the clinic. Copyright ERS 2014. Print ISBN: 978-1-84984-050-7. Online ISBN: 978-1-84984-051-4. Print ISSN: 2312-508X. Online ISSN: 2312-5098. ERS Monogr 2014 64: xi–xii. DOI: 10.1183/1025448x.10003914 xi
Previous Page Next Page